We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




3D Biophotonic Imaging Software

By Biotechdaily staff writers
Posted on 27 May 2005
A new three-dimensional (3D) software analysis system enables scientists to better visualize, monitor, and determine biologic processes in living animals noninvasively and in real-time.

The software, developed by Xenogen Corp. More...
(Alameda, CA, USA), is called Living Image and was designed for Xenogen's IVIS imaging system 3D, but is also compatible with the company's IVIS imaging system 200. This new software provides more spatially accurate and quantitative data than the current software. It includes new tools that enable researchers to more precisely locate in 3D and quantify the signal strength of bioluminescent reporters (glowing tags that light up targeted biologic processes) in living animals.

The software includes a 3D analysis tool called DLIT, which the company claims is the first of its kind for determining the size, location, and brightness of the bioluminescent reporters and therefore creates a more spatially precise image. The first step in the DLIT process involves acquiring a laser-scanned structured light image, which the software processes to determine the surface shape (topography) of the animal. Second, a sequence of luminescent images is acquired through different light filters ranging in wavelength from 560-660 nm. Because the absorption of light in tissue is dependent on its wavelength, this spectrum helps spatially orient the location of the light source. Combined with the surface topography data, the software then analyzes and processes these images to determine the 3D location and shape of the bioluminescent reporter.

"Xenogen's new Living Image software 3D analysis package is a great addition to our portfolio because it improves upon the predictive quality of the data through enhanced localization of the light signal produced by our biophotonic imaging technology,” said Pamela R. Contag, Ph.D., president of Xenogen. "Using the new software, scientists can better pinpoint the location of tumors, as well as the effect of drugs on a tumor and the surrounding tissue.”

Xenogen holds exclusive patent rights to the fundamental technology for real-time in vivo biophotonic imaging. The company incorporated the bioluminescent gene that generates a firefly glow into the microorganisms it uses as biological tags.




Related Links:
Xenogen

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Rheumatoid Factors (RF) Test
Rheumatoid Factors (RF)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.